NFE2L2/KEAP1/CUL3 mutant-targeting agent MGY825
Term · Oncology and biomedicine · MLC-T-ONC-015499
An antineoplastic agent targeting mutant forms of nuclear factor erythroid 2-related factor 2 protein (NFE2L2), Kelch-like ECH-associated protein 1 (KEAP1), and Cullin-3 (CUL3), with potential antineoplastic activity. Upon administration, NFE2L2/KEAP1/CUL3 mutant-targeting agent MGY825 inhibits the activity of NFE2L2, KEAP1 and CUL3 mutant forms, thereby halting the proliferation of NFE2L2, KEAP1, and CUL3 mutant-expressing tumor cells. NFE2L2/KEAP1/CUL3 are mutated in certain tumor cell types.
| Identifier | MLC-T-ONC-015499 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015499",
"term": "NFE2L2/KEAP1/CUL3 mutant-targeting agent MGY825",
"field": "Oncology and biomedicine",
"definition": "An antineoplastic agent targeting mutant forms of nuclear factor erythroid 2-related factor 2 protein (NFE2L2), Kelch-like ECH-associated protein 1 (KEAP1), and Cullin-3 (CUL3), with potential antineoplastic activity. Upon administration, NFE2L2/KEAP1/CUL3 mutant-targeting agent MGY825 inhibits the activity of NFE2L2, KEAP1 and CUL3 mutant forms, thereby halting the proliferation of NFE2L2, KEAP1, and CUL3 mutant-expressing tumor cells. NFE2L2/KEAP1/CUL3 are mutated in certain tumor cell types.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nfe2l2-keap1-cul3-mutant-targeting-agent-mgy825/"
}
Record 11,797 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.